Non-Genetic Influences on CF Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures and Healthcare Interventions

Pediatric Pulmonology

Volumn 37, Issue SUPPL. 26, 2004, Pages 82-85

  Schechter, Michael S ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CYSTIC FIBROSIS; DEMOGRAPHY; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; GENDER; HUMAN; NUTRITIONAL DEFICIENCY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; STRESS; AIR POLLUTANT; ARTICLE; MENTAL STRESS; NUTRITIONAL STATUS; PRACTICE GUIDELINE; SEX DIFFERENCE; SOCIOECONOMICS; TREATMENT REFUSAL;

AIR POLLUTANTS; CHILD; CYSTIC FIBROSIS; HUMANS; NUTRITIONAL STATUS; PRACTICE GUIDELINES; SEX FACTORS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; TREATMENT REFUSAL;

EID: 1242291873     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.70061     Document Type: Review

References (39)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2001 Annual Data Report. In: Bethesda, Maryland; 2002.
2. Mackenbach JP, Kunst AE, Cavelaars AE, Groenhof F, Geurts JJ. Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet 1997;349:1655-9.
3. Britton J. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ 1989;298:483-7.
4. Schechter MS, Shelton BJ, Margolis PA, FitzSimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-7.
5. O'Connor GT, Quinton HB, Kneeland T, Kahn R, Lever T, Maddock J, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003;111:e333-9.
6. Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Annals of Internal Medicine 1998;129:406-11.
7. Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. New England Journal of Medicine 1990;323:782-8.
8. Schuster MA, Franke T, Pham CB. Smoking patterns of household members and visitors in homes with children in the United States. Arch Pediatr Adolesc Med 2002;156:1094-100.
9. Reijneveld SA. The impact of individual and area characteristics on urban socioeconomic differences in health and smoking. International Journal of Epidemiology 1998;27:33-40.
10. Schechter MS. Poverty and Disease Severity in CF: Social and Biological Implications. Pediatr Pulmonol 1999;Suppl 19:156-7.
11. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. Journal of Pediatrics 2001;138:699-704.
12. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-52.
13. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003;35:257-62.
14. Ratjen F, Comes G, Paul K, Posselt HG, Wagner TO, Harms K. Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Pediatr Pulmonol 2001;31:13-6.
15. Jones AM, Dodd ME, Doherty CJ, Govan JR, Webb AK. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 2002;57:924-5.
16. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998;26:81-8.
17. Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. Pediatr Infect Dis J 1990;9:494-8.
18. Armstrong D, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998;26:371-9.
19. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002;57:142-5.
20. Hiatt PW, Grace SC, Kozinetz CA, Raboudi SH, Treece DG, Taber LH, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999;103:619-26.
21. Patterson JM, Budd J, Goetz D, Warwick WJ. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics 1993;91:383-9.
22. Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis. Current Opinion In Pulmonary Medicine 1996;2:457-61.
23. Schoni MH, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clinical Nutrition 2000;19:79-85.
24. Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. Journal of Psychosomatic Research 1999;47:623-34.
25. Rosenfeld M, Davis R, FitzSimmons R, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. American Journal of Epidemiology 1997;145:794-803.
26. Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis. Soc Sci Med 2001;53:1163-74.
27. Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis. J Hum Nutr Diet 2001;14:83-91.
28. Orenstein DM, Nixon PA. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function. Pediatr Pulmonol 1991;10:101-5.
29. Collins CE, MacDonald-Wicks L, Rowe S, O'Loughlin EV, Henry RL. Normal growth in cystic fibrosis associated with a specialised centre. Archives of Disease in Childhood 1999;81:241-6.
30. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatric Pulmonology 1999;28:242-7.
31. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatric Pulmonology 1999;28:248-54.
32. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003;123:20-7.
33. Schechter MS. Demographic and Center-Related Characteristics Associated with Low Weight in Pediatric CF Patients. Pediatric Pulmonology 2002.
34. Institute of Medicine Committee on Quality Health Care in America. Crossing the Quality Chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press; 2001.
35. Quittner AL, Drotar D, Ievers-Landis C, Seidner D, Slocum N, Jacobsen J. Adherence to medical teatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions. In: Drotar D, editor. Promoting adherence to medical treatment in childhood chronic illness: Concepts, methods, and interventions. Mahwah, NJ: Erlbaum Associates; 2000.
36. Eddy ME, Carter BD, Kronenberger WG, Conradsen S, Eid NS, Bourland SL, et al. Parent relationships and compliance in cystic fibrosis. Journal of Pediatric Health Care 1998;12:196-202.
37. DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA 1994;271:79-82.
38. Henley LD, Hill ID. Errors, gaps, and misconceptions in the disease-related knowledge of cystic fibrosis patients and their families. Pediatrics 1990;85:1008-1014.
39. Wright RJ, Steinbach SF. Violence: an unrecognized environmental exposure that may contribute to greater asthma morbidity in high risk inner-city populations. Environ Health Perspect 2001;109:1085-9.